Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Jounce Therapeutics Q4 EPS $(0.59) Misses $(0.32) Estimate

Jounce Therapeutics (NASDAQ:JNCE) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.32) by 84.37 percent. This is a 168.6 percent decrease over earnings of $0.86 per share
byBill Haddad
March 2, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Jounce Therapeutics (NASDAQ:JNCE) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.32) by 84.37 percent. This is a 168.6 percent decrease over earnings of $0.86 per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts